Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Nov 14 - Nov 19
Inhibit osteoclast activation and differentiation, reduce bone resorption Block osteoclast differentiation signal RANKL/RANK/OPG pathway: AOD 9604 downregulates the expression of RANKL (a key factor in osteoclast differentiation) and upregulates the expression of OPG (a RANKL antagonist), reducing the RANKL/OPG ratio by 50-60% and blocking the differentiation of osteoclast precursors into mature osteoclasts
These products offered medical-grade quality with physician oversight
PMID: 30074168
Impact of Updated Data: Additionally, we estimate a change of 384 submissions due to the availability of updated data and assumptions
US$ 27.37
US$ 24.52
US$ 20.92
US$ 26.88
US$ 20.63
US$ 29.52
US$ 26.20
